tiprankstipranks
Trending News
More News >
Vigil Neuroscience Inc (VIGL)
NASDAQ:VIGL
US Market

Vigil Neuroscience Inc (VIGL) Stock Forecast & Price Target

Compare
404 Followers
See the Price Targets and Ratings of:

VIGL Analyst Ratings

Hold
8Ratings
Hold
0 Buy
8 Hold
0 Sell
Based on 8 analysts giving stock ratings to
Vigil
Neuroscience Inc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

VIGL Stock 12 Month Forecast

Average Price Target

$8.00
▲(1.52%Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Vigil Neuroscience Inc in the last 3 months. The average price target is $8.00 with a high forecast of $8.00 and a low forecast of $8.00. The average price target represents a 1.52% change from the last price of $7.88.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","9":"$9","2.25":"$2.25","4.5":"$4.5","6.75":"$6.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$8.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$8.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$8.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,2.25,4.5,6.75,9],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.93,7.935384615384615,7.940769230769231,7.946153846153846,7.951538461538461,7.9569230769230765,7.962307692307692,7.967692307692308,7.973076923076923,7.978461538461539,7.983846153846153,7.989230769230769,7.9946153846153845,{"y":8,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.93,7.935384615384615,7.940769230769231,7.946153846153846,7.951538461538461,7.9569230769230765,7.962307692307692,7.967692307692308,7.973076923076923,7.978461538461539,7.983846153846153,7.989230769230769,7.9946153846153845,{"y":8,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.93,7.935384615384615,7.940769230769231,7.946153846153846,7.951538461538461,7.9569230769230765,7.962307692307692,7.967692307692308,7.973076923076923,7.978461538461539,7.983846153846153,7.989230769230769,7.9946153846153845,{"y":8,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.18,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.37,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.01,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.48,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.35,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.87,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.4,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.7,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.38,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.42,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.68,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.56,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.93,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$8.00Average Price Target$8.00Lowest Price Target$8.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on VIGL
Myles MinterWilliam Blair
William Blair
Hold
Reiterated
06/04/25
Hold Rating on Vigil Neuroscience Inc Amidst Acquisition and Trial Outcomes
Mizuho Securities Analyst forecast on VIGL
Graig SuvannavejhMizuho Securities
Mizuho Securities
$8
Hold
1.52%
Upside
Reiterated
06/04/25
Mizuho Securities Keeps Their Hold Rating on Vigil Neuroscience Inc (VIGL)
H.C. Wainwright Analyst forecast on VIGL
Andrew FeinH.C. Wainwright
H.C. Wainwright
$14$8
Hold
1.52%
Upside
Downgraded
05/28/25
Hold Rating on Vigil Neuroscience Amid Sanofi Acquisition and VG-3927 Developments
Stifel Nicolaus Analyst forecast on VIGL
Paul MatteisStifel Nicolaus
Stifel Nicolaus
$11$8
Hold
1.52%
Upside
Downgraded
05/28/25
Vigil Neuroscience Inc (VIGL) was downgraded to a Hold Rating at Stifel Nicolaus
Guggenheim Analyst forecast on VIGL
Yatin SunejaGuggenheim
Guggenheim
$8
Hold
1.52%
Upside
Downgraded
05/22/25
Vigil Neuroscience downgraded to Neutral from Buy at GuggenheimVigil Neuroscience downgraded to Neutral from Buy at Guggenheim
Wedbush
$13$8
Hold
1.52%
Upside
Downgraded
05/22/25
Vigil Neuroscience downgraded to Neutral from Outperform at WedbushVigil Neuroscience downgraded to Neutral from Outperform at Wedbush
Jefferies Analyst forecast on VIGL
Andrew TsaiJefferies
Jefferies
$19$8
Hold
1.52%
Upside
Downgraded
05/22/25
Vigil Neuroscience downgraded to Hold from Buy at JefferiesVigil Neuroscience downgraded to Hold from Buy at Jefferies
Citizens JMP Analyst forecast on VIGL
Jason ButlerCitizens JMP
Citizens JMP
Hold
Downgraded
05/22/25
Vigil Neuroscience downgraded to Market Perform from Outperform at Citizens JMPVigil Neuroscience downgraded to Market Perform from Outperform at Citizens JMP
Morgan Stanley Analyst forecast on VIGL
Jeffrey HungMorgan Stanley
Morgan Stanley
$4
Sell
-49.24%
Downside
Reiterated
11/26/24
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (NASDAQ: ALNY), Vigil Neuroscience Inc (NASDAQ: VIGL) and Biohaven Ltd. (NYSE: BHVN)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
William Blair Analyst forecast on VIGL
Myles MinterWilliam Blair
William Blair
Hold
Reiterated
06/04/25
Hold Rating on Vigil Neuroscience Inc Amidst Acquisition and Trial Outcomes
Mizuho Securities Analyst forecast on VIGL
Graig SuvannavejhMizuho Securities
Mizuho Securities
$8
Hold
1.52%
Upside
Reiterated
06/04/25
Mizuho Securities Keeps Their Hold Rating on Vigil Neuroscience Inc (VIGL)
H.C. Wainwright Analyst forecast on VIGL
Andrew FeinH.C. Wainwright
H.C. Wainwright
$14$8
Hold
1.52%
Upside
Downgraded
05/28/25
Hold Rating on Vigil Neuroscience Amid Sanofi Acquisition and VG-3927 Developments
Stifel Nicolaus Analyst forecast on VIGL
Paul MatteisStifel Nicolaus
Stifel Nicolaus
$11$8
Hold
1.52%
Upside
Downgraded
05/28/25
Vigil Neuroscience Inc (VIGL) was downgraded to a Hold Rating at Stifel Nicolaus
Guggenheim Analyst forecast on VIGL
Yatin SunejaGuggenheim
Guggenheim
$8
Hold
1.52%
Upside
Downgraded
05/22/25
Vigil Neuroscience downgraded to Neutral from Buy at GuggenheimVigil Neuroscience downgraded to Neutral from Buy at Guggenheim
Wedbush
$13$8
Hold
1.52%
Upside
Downgraded
05/22/25
Vigil Neuroscience downgraded to Neutral from Outperform at WedbushVigil Neuroscience downgraded to Neutral from Outperform at Wedbush
Jefferies Analyst forecast on VIGL
Andrew TsaiJefferies
Jefferies
$19$8
Hold
1.52%
Upside
Downgraded
05/22/25
Vigil Neuroscience downgraded to Hold from Buy at JefferiesVigil Neuroscience downgraded to Hold from Buy at Jefferies
Citizens JMP Analyst forecast on VIGL
Jason ButlerCitizens JMP
Citizens JMP
Hold
Downgraded
05/22/25
Vigil Neuroscience downgraded to Market Perform from Outperform at Citizens JMPVigil Neuroscience downgraded to Market Perform from Outperform at Citizens JMP
Morgan Stanley Analyst forecast on VIGL
Jeffrey HungMorgan Stanley
Morgan Stanley
$4
Sell
-49.24%
Downside
Reiterated
11/26/24
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (NASDAQ: ALNY), Vigil Neuroscience Inc (NASDAQ: VIGL) and Biohaven Ltd. (NYSE: BHVN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Vigil Neuroscience Inc

1 Month
xxx
Success Rate
3/5 ratings generated profit
60%
Average Return
+6.84%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +6.84% per trade.
3 Months
xxx
Success Rate
3/5 ratings generated profit
60%
Average Return
+11.44%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +11.44% per trade.
1 Year
Jeffrey HungMorgan Stanley
Success Rate
1/5 ratings generated profit
20%
Average Return
-84.22%
reiterated a sell rating 7 months ago
Copying Jeffrey Hung's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -84.22% per trade.
2 Years
xxx
Success Rate
0/5 ratings generated profit
0%
Average Return
-118.46%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -118.46% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VIGL Analyst Recommendation Trends

Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
4
7
5
5
1
Buy
2
2
3
5
4
Hold
0
0
0
9
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
9
8
19
16
In the current month, VIGL has received 5 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. VIGL average Analyst price target in the past 3 months is 8.00.
Each month's total comprises the sum of three months' worth of ratings.

VIGL Financial Forecast

VIGL Earnings Forecast

Next quarter’s earnings estimate for VIGL is -$0.42 with a range of -$0.50 to -$0.34. The previous quarter’s EPS was -$0.49. VIGL beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.05% of the time in the same period. In the last calendar year VIGL has Outperformed its overall industry.
Next quarter’s earnings estimate for VIGL is -$0.42 with a range of -$0.50 to -$0.34. The previous quarter’s EPS was -$0.49. VIGL beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.05% of the time in the same period. In the last calendar year VIGL has Outperformed its overall industry.
No data currently available

VIGL Sales Forecast

Next quarter’s sales forecast for VIGL is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. VIGL beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.46% of the time in the same period. In the last calendar year VIGL has Preformed in-line its overall industry.
Next quarter’s sales forecast for VIGL is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. VIGL beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.46% of the time in the same period. In the last calendar year VIGL has Preformed in-line its overall industry.

VIGL Stock Forecast FAQ

What is VIGL’s average 12-month price target, according to analysts?
Based on analyst ratings, Vigil Neuroscience Inc’s 12-month average price target is 8.00.
    What is VIGL’s upside potential, based on the analysts’ average price target?
    Vigil Neuroscience Inc has 1.52% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is VIGL a Buy, Sell or Hold?
          Vigil Neuroscience Inc has a consensus rating of Hold which is based on 0 buy ratings, 8 hold ratings and 0 sell ratings.
            What is Vigil Neuroscience Inc’s price target?
            The average price target for Vigil Neuroscience Inc is 8.00. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $8.00 ,the lowest forecast is $8.00. The average price target represents 1.52% Increase from the current price of $7.88.
              What do analysts say about Vigil Neuroscience Inc?
              Vigil Neuroscience Inc’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of VIGL?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis